Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0K6JQ
|
||||
| Former ID |
DIB012513
|
||||
| Drug Name |
INO-3401
|
||||
| Synonyms |
DNA vaccine (intradermal Cellectra electroporation, H5N1 influenza), Inovio
|
||||
| Drug Type |
Vaccine
|
||||
| Indication | Influenza A virus H5N1 [ICD9: 487, 488; ICD10:J10, J11] | Phase 1 | [1] | ||
| Company |
Inovio pharmaceuticals
|
||||
| Target and Pathway | |||||
| Target(s) | Human DNA | Target Info | [2] | ||
| References | |||||
| REF 1 | ClinicalTrials.gov (NCT01405885) A Study of DNA Vaccine With Electroporation for the Prevention of Disease Caused by H1 and H5 Influenza Virus. U.S. National Institutes of Health. | ||||
| REF 2 | ClinicalTrials.gov (NCT01403155) A Follow-On Study With an H5 Influenza Vaccine for Subjects Who Participated in Study FLU-001. U.S. National Institutes of Health. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.